Daily non-political popular news in brief.
Researchers find deadly prescription drug effects 6 years before FDA
05-28-2007 · EurekAlert!Northwestern University's national SWAT team of doctor sleuths called RADAR (Research on Adverse Drug Events and Reports) identifies deadly prescription drug reactions six years before the FDA and drug companies. RADAR also provides more comprehensive reports with important medical insights as well as guidance for prevention, diagnosis and treatment.
Read more »
Keywords: researchers, deadly, prescription, drug, effects, fda, researcher, effect
« Previous | Next »
Similar news on "Researchers find deadly prescription drug effects 6 years before FDA":
- Researchers Find Deadly Prescription Drug Effects Six Years Before FDA
05-28-2007 · EurekAlert!
Northwestern University's national SWAT team of doctor sleuths called RADAR (Research on Adverse Drug Events and Reports) identifies deadly prescription drug reactions six years before the FDA and drug companies. RADAR also provides more comprehensive reports with important medical insights as well as guidance for prevention, diagnosis and treatment.
Similar news · Read more »
- Another 'smart' cancer drug can have toxic effects on the heart
12-13-2007 · EurekAlert!
Another FDA-approved targeted cancer drug, sunitinib, may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia). Sunitinib is one of several new "smart" cancer drugs called tyrosine kinase inhibitors that targets specific signaling molecules inside cancer cells that aid cancer spread, and was originally thought to be relatively free of cardiac side effects.
Similar news · Read more »
- Stress triggers relapse in meth abuse, OHSU study finds
10-18-2006 · EurekAlert!
Oregon Health & Science University research showing stress triggers relapse of methamphetamine abuse in mice could be a step toward developing a drug to curb this frustrating obstacle to recovery. Results of the study not only validate earlier studies on the effects of stress on drug relapse in humans, they also show a compound researchers used to mimic metabolic changes that occur during stress creates a useful model for studying this effect in the laboratory.
Similar news · Read more »
- Does OTC diet pill Alli live up to its name?
06-13-2007 · EurekAlert!
Alli is the first and only FDA-approved OTC product for weight loss. It is available in stores June 15. Dr. James Anderson, UK HealthCare weight loss researcher, studied the effects of the drug on mildly to moderately overweight individuals and found it does aid weight loss.
Similar news · Read more »
- UNC study questions FDA genetic-screening guidelines for cancer drug
08-28-2007 · EurekAlert!
Not everyone needs a genetic test before taking the cancer drug irinotecan, and the US Food and Drug Administration should modify its prescription guidelines to say so, according to researchers at the University of North Carolina at Chapel Hill.
Similar news · Read more »
- Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
01-02-2008 · EurekAlert!
Scientists at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease.
Similar news · Read more »
- Study: Re-engineered Gleevec reduces heart risks
12-03-2007 · EurekAlert!
Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib -- best known by its brand name Gleevec -- to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect. The re-design strategy employed in the study is broadly applicable to reducing side effects in other drugs.
Similar news · Read more »
- Modifying an anti-cancer drug makes it more specific
12-03-2007 · EurekAlert!
Imatinib is used to treat chronic myeloid leukemia and gastrointestinal stromal tumors because they are caused by related proteins. However, this lack of specificity means imatinib also affects normal bodily functions and it has been reported to have a toxic effect on the heart in some patients. Now, researchers have modified imatinib so it inhibits the protein behind GISTs but neither inhibits the protein behind CML nor has toxic effects on the mouse heart.
Similar news · Read more »
- Story ideas from the Journal of Biological Chemistry
01-14-2008 · EurekAlert!
COX-2 inhibitors like Celecoxib have come under scrutiny lately due to adverse cardiovascular side-effects stemming from COX-2 reduction. In both fruit fly and rat models, researchers reveal another adverse effect of Celecoxib; this drug can induce arrhythmia. More interestingly, this effect is independent of the COX-2 enzyme.
Similar news · Read more »
- Researchers propose reason for severe side-effects of Northwick Park clinical trial
01-25-2007 · EurekAlert!
A possible reason why the Northwick Park clinical trial of the drug TGN1412 in the UK caused multiple organ failure in human volunteers is revealed in research presented today at a conference near Paris. The research shows that stimulating the molecule CD28 on cells that mediate the immune response, known as T cells, can have an adverse effect if these immune cells have been activated and altered by infection or illness in the past.
Similar news · Read more »
